Albemarle
ALB Β· Specialty Chemicals
$93.67
1.2%Solstice Advanced Materials
SOLS Β· Specialty Chemicals
$59.42
0.6%The short version
- Albemarle is the larger business, with $5.1B of revenue in fiscal 2025 against $3.9B for Solstice Advanced Materials.
- Solstice Advanced Materials grew revenue faster (3.1%, against β4.4%).
- Albemarle turned more of its sales into free cash flow (13.5% FCF margin, against 3.1% FCF margin).
- Solstice Advanced Materials earned a higher return on the capital invested in it (12.2%, against β2.4%).
| Latest fiscal year | ALB Β· FY25 | SOLS Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $12.8B | $9.5B |
| Revenue | $5.1B | $3.9B |
| Free cash flow | $692M | $119M |
| Net income | β$511M | $237M |
| Growth | ||
| Revenue growth | β4.4% | 3.1% |
| 5-year growth | 10.5% | β |
| Share count change | 0.1% | 0.1% |
| Profitability | ||
| Gross margin | 13.0% | 32.2% |
| Operating margin | β7.1% | β |
| Net margin | β9.9% | 6.1% |
| FCF margin | 13.5% | 3.1% |
| Return on capital | β2.4% | 12.2% |
| Return on equity | β5.2% | 10.2% |
| Balance sheet | ||
| Net debt | $1.7B | $1.6B |
| Net debt / EBITDA | 5.8x | 2.3x |
| Dividends and buybacks | $191M | $1.5B |
| Valuation & quality | ||
| P/E | β | β |
| Piotroski F-score | 7 | β |
FY16
ALB $2.7B
SOLS β
FY17
ALB $3.1B
SOLS β
FY18
ALB $3.4B
SOLS β
FY19
ALB $3.6B
SOLS β
FY20
ALB $3.1B
SOLS β
FY21
ALB $3.3B
SOLS β
FY22
ALB $7.3B
SOLS β
FY23
ALB $9.6B
SOLS $3.6B
FY24
ALB $5.4B
SOLS $3.8B
FY25
ALB $5.1B
SOLS $3.9B
ALB
SOLS
FY16
ALB 22.5%
SOLS β
FY17
ALB 18.6%
SOLS β
FY18
ALB 27.0%
SOLS β
FY19
ALB 18.6%
SOLS β
FY20
ALB 16.2%
SOLS β
FY21
ALB 24.0%
SOLS β
FY22
ALB 33.7%
SOLS β
FY23
ALB 2.6%
SOLS β
FY24
ALB β33.0%
SOLS β
FY25
ALB β7.1%
SOLS β
ALB
SOLS
FY16
ALB $539M
SOLS β
FY17
ALB β$13.7M
SOLS β
FY18
ALB β$154M
SOLS β
FY19
ALB β$132M
SOLS β
FY20
ALB β$51.6M
SOLS β
FY21
ALB β$609M
SOLS β
FY22
ALB $646M
SOLS β
FY23
ALB β$828M
SOLS $461M
FY24
ALB β$993M
SOLS $546M
FY25
ALB $692M
SOLS $119M
ALB
SOLS
FY16
ALB β
SOLS β
FY17
ALB 6.7%
SOLS β
FY18
ALB 15.8%
SOLS β
FY19
ALB 9.8%
SOLS β
FY20
ALB 6.2%
SOLS β
FY21
ALB 8.2%
SOLS β
FY22
ALB 23.3%
SOLS β
FY23
ALB 1.1%
SOLS β
FY24
ALB β10.9%
SOLS β
FY25
ALB β2.4%
SOLS 12.2%
ALB
SOLS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.